Get notified when BF-B files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsBrown-Forman Q1 sales slip 1% to $1.18B; EPS rises 6% to $0.38 on lower costs
Filed September 2, 2026 · Period ending July 31, 2026 · Compared to 10-Q Aug 28, 2025 · ~1 min read
Key Changes
-
high
Net sales fell 1% to $1.18B in Q1 FY27, driven by unfavorable price/mix and the end of the Korbel relationship, partially offset by higher volumes and favorable FX.
MD&A: Net sales verify on EDGAR → -
high
Operating income declined 3% to $252M, as higher operating expenses more than offset gross margin expansion.
MD&A: Operating income verify on EDGAR → -
high
Diluted EPS rose 6% to $0.38, helped by lower non-operating postretirement expense and share buybacks, despite the operating income decline.
MD&A: Diluted EPS verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IMMR 10-Q) is open in full — no account needed.
Partner
Trade BF-B commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 17, 2026 · How we verify